Daniela J. Conrado

863 total citations
35 papers, 509 citations indexed

About

Daniela J. Conrado is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniela J. Conrado has authored 35 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniela J. Conrado's work include Drug Solubulity and Delivery Systems (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Daniela J. Conrado is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Daniela J. Conrado collaborates with scholars based in United States, Brazil and Argentina. Daniela J. Conrado's co-authors include Teresa Dalla Costa, Klaus Romero, Hartmut Derendorf, Jackson Burton, Daniel González, Sarah Kim, Bibiana Verlindo de Araújo, Danny Chen, Ursula Theuretzbacher and Kaori Ito and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and Critical Care Medicine.

In The Last Decade

Daniela J. Conrado

35 papers receiving 498 citations

Peers

Countries citing papers authored by Daniela J. Conrado

Since Specialization

Citations

This map shows the geographic impact of Daniela J. Conrado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela J. Conrado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela J. Conrado more than expected).

Fields of papers citing papers by Daniela J. Conrado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela J. Conrado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela J. Conrado. The network helps show where Daniela J. Conrado may publish in the future.

Co-authorship network of co-authors of Daniela J. Conrado

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela J. Conrado. A scholar is included among the top collaborators of Daniela J. Conrado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela J. Conrado. Daniela J. Conrado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Sarah Kim, Rebecca J. Willcocks, Michael J. Daniels, (unknown), (unknown), William Triplett, (unknown), Daniela J. Conrado, Varun Aggarwal, (unknown), Terina N. Martinez, Glenn A. Walter, William D. Rooney, Krista Vandenborne	8
2	Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV‐2 2022 ·Clinical Pharmacology & Therapeutics ·(unknown), Andreas Kuznik, (unknown), Witold Więcek, Mohamed Hussein, Hazem E. Hassan, Kashyap Patel, Thomas Obadia, (unknown), Daniela J. Conrado, Nidal Al‐Huniti, Roman Casciano, Meagan P. O’Brien, Ruanne V. Barnabas, Myron S. Cohen, Patrick F. Smith	1
3	Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy 2021 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Varun Aggarwal, (unknown), Daniela J. Conrado, Diane Corey, (unknown), Jackson Burton, Jane Larkindale, Klaus Romero, Stephan Schmidt, Sarah Kim	20
4	Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease 2019 ·Clinical and Translational Science ·Klaus Romero, Daniela J. Conrado, Jackson Burton, Timothy Nicholas, Vikram Sinha, Sreeraj Macha, Malidi Ahamadi, Jesse M. Cedarbaum, John Seibyl, Kenneth Marek, (unknown), David Hill, (unknown), Jill Gallagher, David T. Dexter, Arthur Roach, Diane Stephenson, (unknown)	12
5	Genome‐Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β‐Blockers 2018 ·Journal of the American Heart Association ·Mohamed H. Shahin, Daniela J. Conrado, Daniel González, Yan Gong, Maximilian T. Lobmeyer, Amber L. Beitelshees, Eric Boerwinkle, John G. Gums, Arlene B. Chapman, Stephen T. Turner, Rhonda M. Cooper‐DeHoff, Julie A. Johnson	20
6	Open innovation: Towards sharing of data, models and workflows 2017 ·European Journal of Pharmaceutical Sciences ·Daniela J. Conrado, Mats O. Karlsson, Klaus Romero, Céline Sarr, Justin Wilkins	26
7	Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis 2017 ·Clinical and Translational Science ·Daniela J. Conrado, Timothy Nicholas, Kuenhi Tsai, Sreeraj Macha, Vikram Sinha, Julie A. Stone, Brian Corrigan, Massimo Bani, Pierandrea Muglia, Ian A. Watson, (unknown), Елена Шевелева, Kenneth Marek, Diane Stephenson, Klaus Romero, (unknown)	35
8	Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose–response analysis 2016 ·Journal of Pharmacokinetics and Pharmacodynamics ·Daniela J. Conrado, Sriram Krishnaswami, Satoshi Shoji, Sheela Kolluri, Judith Hey‐Hadavi, Dorothy McCabe, Ricardo Rojo, (unknown)	17
9	An updated Alzheimer’s disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM 2014 ·Journal of Pharmacokinetics and Pharmacodynamics ·Daniela J. Conrado, William S. Denney, Danny Chen, Kaori Ito	26
10	Electroencephalogram effects of armodafinil: Comparison with behavioral alertness 2013 ·The Journal of Clinical Pharmacology ·Daniela J. Conrado, (unknown), Mingzhou Ding, Jean E. Cibula, Christoph N. Seubert, Sherwin K. B. Sy, Stephan Eisenschenk, Hartmut Derendorf	4
11	A Markov Chain Model to Evaluate the Effect of CYP3A5 and ABCB1 Polymorphisms on Adverse Events Associated with Tacrolimus in Pediatric Renal Transplantation 2013 ·The AAPS Journal ·Sherwin K. B. Sy, Jules A. A. C. Heuberger, Sireen Abdul Rahim Shilbayeh, Daniela J. Conrado, Hartmut Derendorf	9
12	The Effect of Critical Illness on Drug Distribution 2011 ·Current Pharmaceutical Biotechnology ·Daniel González, Daniela J. Conrado, Ursula Theuretzbacher, Hartmut Derendorf	29
13	Role of drug absorption in the pharmacokinetics of therapeutic interventions for stroke 2010 ·Annals of the New York Academy of Sciences ·Daniela J. Conrado, Daniel González, Hartmut Derendorf	3
14	Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats 2010 ·European Journal of Pharmaceutical Sciences ·Letícia Cruz, (unknown), Sérgio Faloni de Andrade, Daniela J. Conrado, Irene Clemes Külkamp‐Guerreiro, Sı́lvia Stanisçuaski Guterres, Adriana Raffin Pohlmann	15
15	Microencapsulation of sodium alendronate reduces drug mucosal damage in rats 2010 ·Drug Delivery ·Letícia Cruz, (unknown), Sérgio Faloni de Andrade, Daniela J. Conrado, Sı́lvia Stanisçuaski Guterres, Adriana Raffin Pohlmann	12
16	Pharmacokinetic evaluation of LASSBio-579: anN-phenylpiperazine antipsychotic prototype 2008 ·Journal of Pharmacy and Pharmacology ·Daniela J. Conrado, Hugo Verli, Gilda Neves, Carlos Alberto Manssour Fraga, Eliezer J. Barreiro, Stela Maris Kuze Rates, Teresa Dalla Costa	32
17	Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581 2007 ·Pharmacology Biochemistry and Behavior ·Gilda Neves, (unknown), Andresa Heemann Betti, Daniela J. Conrado, Leandro Tasso, Carlos Alberto Manssour Fraga, Eliezer J. Barreiro, Teresa Dalla Costa, Stela Maris Kuze Rates	14
18	Validation of rapid and simple LC–MS/MS method for determination of voriconazole in rat plasma 2007 ·Journal of Pharmaceutical and Biomedical Analysis ·Bibiana Verlindo de Araújo, Daniela J. Conrado, (unknown), Teresa Dalla Costa	31
19	High performance liquid chromatography method for quantification of the N-phenylpiperazine derivative LASSBio-579 in rat plasma 2007 ·Química Nova ·Daniela J. Conrado, Stela Maris Kuze Rates, Teresa Dalla Costa, Carlos Alberto Manssour Fraga, Eliezer J. Barreiro	1
20	Development and validation of a LC-MS/MS method with electrospray ionization for determination of LASSBio-579 in rat plasma 2006 ·Journal of Pharmaceutical and Biomedical Analysis ·Daniela J. Conrado, (unknown), Carlos Alberto Manssour Fraga, Eliezer J. Barreiro, Stela Maris Kuze Rates, Teresa Dalla Costa	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact